Medical/Pharmaceuticals
XSENSOR Earns the Frost & Sullivan 2022 Technology Innovation Leadership Award for Intelligent Dynamic Sensing Systems
Delivers innovative pressure measurement solutions to the world's most demanding customers. SAN ANTONIO, Sept. 29, 2022 /PRNewswire/ -- Based on its recent analysis of the sensor technology in the medical devices market,Frost & Sullivan recognizes XSENSOR Technology Corporation with the 2022 Nor...
2022-09-29 21:00
1810
'Generations Connect' Project Brings Young People Together with the Elderly to Boost Emotional Resilience
Engaging tailored e-platform and healthcare students promote the wellbeing of the elderly HONG KONG, Sept. 29, 2022 /PRNewswire/ -- In recent years due to the COVID-19 pandemic, elderly people have had to stay mostly at home. Confined to small living spaces for prolonged periods, many senior cit...
2022-09-29 17:37
4505
Manulife Hong Kong research reveals attitude shift on how Hongkongers live with COVID-19
* Hong Kong residents are trying to regain normalcy in daily lives * Mental and physical health in decline * Majority of respondents concerned about spread of another unknown disease in Hong Kong HONG KONG, Sept. 29, 2022 /PRNewswire/ -- Manulife Hong Kong today announced the results of its h...
2022-09-29 13:13
4327
Green Mountain Biotech and Kamedis Announce First Patent in China for Unique Herb-Based Acne and Skin Relief Solution
Clinically-tested solution, based on a proprietary blend of six herbs used in
Traditional Chinese Medicine, helps relieve symptoms of acne and other skin
inflammation conditions.
TEL AVIV, Israel, Sept. 29, 2022 /PRNewswire/ -- Green Mountain Biotech
2022-09-29 09:00
3719
Green Mountain Biotech and Kamedis Announce First Patent in China for Unique Herb-Based Acne and Skin Relief Solution
Clinically-tested solution, based on a proprietary blend of six herbs used in
Traditional Chinese Medicine, helps relieve symptoms of acne and other skin
inflammation conditions.
TEL AVIV, Israel, Sept. 29, 2022 /PRNewswire/ -- Green Mountain Biotech
2022-09-29 09:00
2309
CLIMATE CHANGE AND HEALTH INEQUITY A DEADLY MIX FOR THE MOST VULNERABLE: WORLD HEART FEDERATION
GENEVA, Sept. 29, 2022 /PRNewswire/ -- On World Heart Day, the World Heart Federation (WHF) is calling for urgent action on climate change and health inequity, saying millions more lives are now at risk from cardiovascular disease, which is still the world's biggest killer. Climate change and ai...
2022-09-29 06:01
3235
ASTRUM-005: The first immunotherapy clinical study of SCLC published in JAMA, one of the top medical journals in the world
* ASTRUM-005 is the first study to demonstrate that PD-1 inhibitors plus chemotherapy can improve survival for patients with ES-SCLC. * In ASTRUM-005, serplulimab combined with chemotherapy achieved by far the longest OS in first-line immunotherapy for ES-SCLC. Compared with chemotherapy, the...
2022-09-28 21:00
3760
ICHNOS SCIENCES ANNOUNCES INITIATION OF FIRST-IN-HUMAN STUDY FOR ISB 1442
First patient dosed with novel biparatopic 2+1 BEAT® bispecific antibody targeting CD38 and CD47 NEW YORK, Sept. 28, 2022 /PRNewswire/ -- Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific immune cell engager antibodies in oncology, today anno...
2022-09-28 20:30
1729
ABILITY DIABETES GLOBAL - A Landmark RCT in the field of PCI for patients with DM, completes Enrolment
TAMPA, Fla., Sept. 28, 2022 /PRNewswire/ -- ABILITY DIABETES-GLOBAL
2022-09-28 20:29
3263
Advanced Instruments Introduces Solentim VIPS™ PRO, A High Efficiency Single Cell Seeder to Optimize Cell Line Development Workflows
VIPS PRO delivers powerful and efficient seeding technology and definitive proof of monoclonality for workflow productivity and confidence. NORWOOD, Mass., Sept. 28, 2022 /PRNewswire/ -- Advanced Instruments today announced the launch ofSolentim VIPS PRO, a high efficiency single cell seeder, at...
2022-09-28 20:05
3702
The IND application of Biosyngen BRG01 Therapy was accepted by CDE
GUANGZHOU, China, Sept. 28, 2022 /PRNewswire/ -- The IND application of
Biosyngen BRG01 Therapy has been accepted for review by the Center for Drug
Evaluation,China (CXSL2200487)（
https://www.cde.org.cn/main/xxgk/listpage/9f9c74c73e0f8f56a8bfbc646055026d
2022-09-28 18:05
5080
Biosyngen Gives Cell Therapy GMP Capabilities in Singapore A Boost
SINGAPORE, Sept. 28, 2022 /PRNewswire/ -- On September 22nd, Biosyngen signed to set up a Cell Therapy GMP Facility which will serve as a base to develop the company's immunotherapy assets to address unmet needs in cancer treatment. Located in Solaris @ Tai Seng, this 1,300 square metres faci...
2022-09-28 17:34
6550
New GHA Certification Helps Medical Tourism Facilitators Build Patient Trust
WEST PALM BEACH, Fla., Sept. 28, 2022 /PRNewswire/ -- Global Healthcare Accreditation (GHA) announces the launch of a new certification program for medical travel facilitators to assist in building patient trust. GHA's Medical Travel Facilitator Certification focuses on validating the capacity ...
2022-09-28 17:00
3299
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology
CAMBRIDGE, England and COPENHAGEN, Denmark, Sept. 28, 2022 /PRNewswire/ -- Vernalis Research ("Vernalis"), a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S ("Contera") are pleased to announce a strategic drug discovery collaboration on an undisclosed target. Under the terms of the...
2022-09-28 16:00
2498
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib
The FDA has assigned a PDUFA goal date of March 29, 2023 for the NDA submission based on randomized-controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency LEIDEN, The Netherlands, Sept. 28, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharmi...
2022-09-28 13:00
3616
Chugai Pharma Taiwan Awarded at the Asia Responsible Enterprise Awards 2022 for 'Cycling for Charity' under Social Empowerment Category
SINGAPORE, Sept. 28, 2022 /PRNewswire/ -- The Asia Responsible Enterprise Awards (AREA) 2022 is pleased to honor 72 exemplary award recipients for championing ESG to build a resilient world and a sustainable future for all. The AREA is the most prominent CSR recognition program across Asia initia...
2022-09-28 12:30
2244
ETANA HAS SECURED B ROUND FINANCING
JAKARTA, Indonesia, Sept. 28, 2022 /PRNewswire/ -- PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured B round of financing led by Yunfeng Capital and followed by HighLight Capital. This round of financing will be mainly used for further strengthening ...
2022-09-28 09:00
6362
Ascletis Announces Dosing of the First Patient in the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure
-- After the pre-Phase III clinical trial meeting with Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) in June 2022, the pathway to the registration, including patient population, dose, treatment duration, etc. of ASC22 (Envafolimab) for functional cure of...
2022-09-28 08:10
3698
Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate
MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved a pivotal Phase III registration study that will bridge ...
2022-09-28 06:50
2472
First Patient in Australia Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent
MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the first commercial dose inAustralia of its prostate cancer imaging agent, Illuccix® (Kit for Preparation of Ga-68 Glu-urea-Lys(ahx)-hbed-CC Injection), also known as...
2022-09-28 05:00
3091
Week's Top Stories
Most Reposted
DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 276 media titles]
2026-10-06 05:28Zenika CTO Adrien Nortain Moves Base to Singapore to Strengthen Technical Leadership in Asia
[Picked up by 271 media titles]
2026-10-01 10:00
ViewSonic Launches VG1457 Dual-Screen Portable Monitor for Productivity Anywhere
[Picked up by 269 media titles]
2026-09-30 10:50
Sunway University to Host Asia's First Global Tipping Points Conference 2026
[Picked up by 263 media titles]
2026-09-30 12:11
Vestas Powers Up Vietnam's Clean Energy Ambitions with Two New Projects Under PDP8 Totaling 16 Wind Turbines
[Picked up by 263 media titles]
2026-10-02 16:27
Most Read
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes
2026-10-02 00:30
23821
